Pinatuzumab (Anti-Siglec-2 / CD22)
Pinatuzumab (Anti-Siglec-2 / CD22)a humanized IgG1 monoclonal antibody targeting CD22. It has potential antineoplastic activity and can be used in research of Non-Hodgkin Lymphoma. MW : 146.64 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A3059 |
| Sku # | A3059-1mg*25 |
| Pricing | 1mg*25, $5070.00 |